The Cyrex System™

Each Patient Is Unique.

AUTOIMMUNE DISORDERS:
A GROWING CONCERN — CYREX CAN HELP

Cyrex is focused on the fast growing health issues of autoimmune disorders now affecting tens of millions of people in the United States. Cyrex test panels are designed to evaluate your immune reactions using our proprietary, advanced technology.
As a CLIA licensed clinical laboratory, our innovative tests provide advanced clinical tools to identify and measure immune reactiviy and possible autoimmune reactivity that can affect multiple tissues such as:

  • Brain
  • Nervous System
  • Thyroid
  • Heart
  • Pancreas
  • Reproductive Organs
  • Liver
  • Gastrointestinal System
  • Bones
  • Joint

Cognitive Health

Identify and address the early signs of
Alzheimer's disease.

Talk to your doctor about:

Alzheimer's LINX - Alzheimer's-Associated Immune Reactivity

Essential Barriers

Evaluation of the intestinal and Blood-brain barrier integrity.

Talk to your doctor about:

Array 2 - Intestinal Antigenic Permeability Screen­™
Array 20 - Blood-Brain Barrier™
Array 22 - Irritable Bowel/SIBO Screen™

Mucosal Immune

The first array to encompass the Cyrex System measuring both SIgA and SIgM

Talk to your doctor about:

Array 14 - Mucosal Immune Reactivity Screen™

The Immune Load Reduction™ System

What is Your Immune Load™?
We help you identify key challenges to your immune system so you can reduce the immune load.
Alzheimer's LINX™ —
Alzheimer's - Associated Immune Reactivity
Alzheimer's LINX™ makes it easier to see the route of pathogenesis leading to cognitive decline, and devise strategies to stop it. By addressing
Blood-brain barrier (BBB) breakdown, identifying and removing triggers and enhancing neuronal regeneration, one might be able to win the war on cognitive decline.
Total Serum IgG/IgA/IgM (GAM)
Acts as a first line of defense before Predictive Antibodies, Barrier Permeability and Environmental Triggers can influence autoimmune reactivity.
Array 2 — Intestinal Antigenic Permeability Screen™
Measure intestinal permeability to large molecules which inflame the immune system and identify the damaging route through the intestinal barrier.
Array 20 — Blood-Brain Barrier Permeability™
Early investigation of contact sports-related Traumatic Brain Injury, evaluation of the
Blood-brain barrier by stress, trauma or environmental triggers.
Array 22 — Irritable Bowel/SIBO Screen™
Assess IgG, IgA and IgM antibodies to bacterial cytotoxins and to cytoskeletal proteins for an accurate measurement of bacterial overgrowth and damage to the intestinal barrier.
Array 3X — Wheat/Gluten Proteome Reactivity & Autoimmunity™
An expanded panel of the wheat/gluten reactivity testing with the introduction of 4 new antigens.
Array 4 — Gluten-Associated Cross-Reactive Foods & Foods Sensitivity™
Identify dietary proteins to the gluten sensitive or Celiac disease patient and detect cross-reactive foods.
Array 10, 10-90 and 10-90X —
Multiple Food Immune Reactivity Screen™
Evaluate immune reactions to foods, raw and/or modified, food enzymes, lectins and artificial food additives, including meat glue, colorings and gums.
Array 11 — Chemical Immune Reactivity Screen™
Identify loss of immune tolerance and assist in setting guidelines for the avoidance of chemicals to reduce the risk of igniting the autoimmune process.
Array 12 — Pathogen-Associated Immune Reactivity Screen™
Pathogen reactivity, fungi, bacterium, virus immune response to latent pathogens.
Array 5 — Multiple Autoimmune Reactivity Screen™
Measure predictive antibodies up to ten years before the clinical onset of disease and assess possible tissue damage to multiple organs of the body.
Array 6 — Diabetes Autoimmune Reactivity Screen™
Assist in the early detection of autoimmune processes of type 1 diabetes, impaired blood sugar metabolism and metabolic syndrome.
Array 7 — Neurological Autoimmune Reactivity Screen™
Assist in the early detection of
neuro-autoimmunity, evaluate autoimmune response and assist in monitoring effectiveness of related treatment protocols.
Array 7X — Neurological Autoimmune Reactivity Screen - Expanded™
Assist in the early detection of
neuro-autoimmunity, evaluate autoimmune response and assist in monitoring effectiveness of related treatment protocols.
Array 8 — Joint Autoimmune Reactivity Screen™
Assist in early detection of mixed connective tissue disorders and monitor the effectiveness of related treatment protocols.
Array 14 — Mucosal Immune Reactivity Screen
Acts as a first line of defense before predictive antibodies, barrier permeability and reactivity triggers can influence autoimmune reactivity.